scholarly article | Q13442814 |
P50 | author | Robert P. Kimberly | Q41183568 |
Graciela S Alarcón | Q67485107 | ||
John D Reveille | Q67485113 | ||
Carl D. Langefeld | Q102208371 | ||
Miranda C. Marion | Q112947458 | ||
Jeffrey C Edberg | Q114385251 | ||
LUMINA Study Group | Q114722503 | ||
Mandar Apte | Q114722505 | ||
P2093 | author name string | Jie Zhang | |
Luis M Vilá | |||
Sergio Durán | |||
P2860 | cites work | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 |
The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE. | Q31143990 | ||
Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE. | Q33331408 | ||
Autoimmune hemolytic anemia in patients with systemic lupus erythematosus | Q33331802 | ||
A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population | Q33332503 | ||
Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. | Q33342337 | ||
Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. | Q33346622 | ||
Lupus thrombocytopenia: clinical implications and prognostic significance | Q33367827 | ||
Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? | Q33369397 | ||
Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus | Q33384656 | ||
Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. | Q33435725 | ||
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody | Q33459225 | ||
The significance of thrombocytopenia in systemic lupus erythematosus | Q33480020 | ||
Hemocytopenia as initial manifestation of systemic lupus erythematosus. Prognostic significance. | Q33480739 | ||
Hematologic aspects of systemic lupus erythematosus. Current concepts | Q33493839 | ||
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus | Q35554492 | ||
Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time | Q35637820 | ||
Autoimmune hemolytic anaemia in the antiphospholipid syndrome | Q36560811 | ||
Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus | Q38290181 | ||
Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique | Q38360359 | ||
Predictors of survival in systemic lupus erythematosus | Q38468220 | ||
Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients | Q40488181 | ||
The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". | Q40541271 | ||
Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody | Q41252488 | ||
A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients | Q42434981 | ||
Learned helplessness in systemic lupus erythematosus: analysis using the Rheumatology Attitudes Index | Q43454995 | ||
Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group | Q43589680 | ||
Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group | Q43654524 | ||
Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture | Q46187058 | ||
Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual | Q46223662 | ||
Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture | Q46430510 | ||
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. | Q50562581 | ||
Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. | Q53614605 | ||
Genetic linkage and association of Fc? receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus | Q57329945 | ||
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus | Q57740770 | ||
Dimensions of illness behaviour as measured by the Illness Behaviour Questionnaire: a replication study | Q70531938 | ||
A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification | Q72293586 | ||
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison | Q73471436 | ||
Baseline characteristics of a multiethnic lupus cohort: PROFILE | Q77956670 | ||
Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual | Q79169566 | ||
Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases | Q83313513 | ||
The measurement of helplessness in rheumatoid arthritis. The development of the arthritis helplessness index | Q93618721 | ||
P433 | issue | 9 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
hemolytic anemia | Q1145668 | ||
multiethnicity | Q111242702 | ||
P304 | page(s) | 1332-1340 | |
P577 | publication date | 2008-09-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort | |
P478 | volume | 59 |
Q64076051 | Acute parenchymal lung involvement in a 68-year-old woman with systemic lupus erythematosus, anemia, and thrombocytopenia |
Q38059457 | Anaemia in inflammatory rheumatic diseases |
Q33436595 | Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients |
Q33389586 | Autoimmune hemolytic anemia in systemic lupus erythematosus: association with thrombocytopenia |
Q57805070 | Changes in Hemoglobin Concentrations Post-immunoglobulin Therapy in Patients with Kawasaki Disease: A Population-Based Study Using a Claims Database in Japan |
Q33431535 | Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome: A Case-Control, Single Center Study |
Q34056050 | Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions. |
Q28301151 | Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus |
Search more.